Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel D Karp

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Journal of Oncology Practice|February 20, 2018
Selecting an Electronic Health Record SystemDaniel D Karp
Clinical Lung Cancer|July 28, 2009
Development of the monoclonal antibody figitumumab, targeting the insulin-like growth factor-1 receptor, for the treatment of patients with non-small-cell lung cancerAntonio Gualberto, Daniel D Karp
Journal of Immunotherapy and Precision Oncology|November 11, 2024
Learning From Mistakes: Navigating Medical Errors in Oncology From Prevention to ManagementDaniel D Karp, Jessica A Osburn, Mohamed A Gouda
Seminars in Thoracic and Cardiovascular Surgery|January 8, 2004
Nonsmall-cell lung cancer: chemoprevention studiesDaniel D Karp, Anne S Tsao, Edward S Kim
Cancer|June 5, 2015
The mu opioid receptor: A new target for cancer therapy?Patrick A Singleton, Jonathan Moss, Daniel D Karp, et al.
Cancer Research|January 26, 2002
Down-regulation and antiproliferative role of C/EBPalpha in lung cancerBalazs Halmos, Claudia S Huettner, Olivier Kocher, et al.
Cancer|January 24, 2009
The changing face of phase 1 cancer clinical trials: new challenges in study requirementsBarbara S Craft, Razelle Kurzrock, Xiudong Lei, et al.
Eclinicalmedicine|June 24, 2022
Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumoursDaniel D Karp, D Ross Camidge, Jeffery R Infante, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Phase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancerWilliam N William, Ralph G Zinner, Daniel D Karp, et al.
Journal of Clinical and Translational Science|February 22, 2024
Simultaneous submission of seven CTSA proposals: UM1, K12, R25, T32-predoctoral, T32-postdoctoral, and RC2: strategies, evaluation, and lessons learnedCarolina Lema, Kwai Wa Cheng, Delanderia M Anderson, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Journal of Oncology Practice|February 20, 2018
Selecting an Electronic Health Record SystemDaniel D Karp
Clinical Lung Cancer|July 28, 2009
Development of the monoclonal antibody figitumumab, targeting the insulin-like growth factor-1 receptor, for the treatment of patients with non-small-cell lung cancerAntonio Gualberto, Daniel D Karp
Journal of Immunotherapy and Precision Oncology|November 11, 2024
Learning From Mistakes: Navigating Medical Errors in Oncology From Prevention to ManagementDaniel D Karp, Jessica A Osburn, Mohamed A Gouda
Seminars in Thoracic and Cardiovascular Surgery|January 8, 2004
Nonsmall-cell lung cancer: chemoprevention studiesDaniel D Karp, Anne S Tsao, Edward S Kim
Cancer|June 5, 2015
The mu opioid receptor: A new target for cancer therapy?Patrick A Singleton, Jonathan Moss, Daniel D Karp, et al.
Cancer Research|January 26, 2002
Down-regulation and antiproliferative role of C/EBPalpha in lung cancerBalazs Halmos, Claudia S Huettner, Olivier Kocher, et al.
Cancer|January 24, 2009
The changing face of phase 1 cancer clinical trials: new challenges in study requirementsBarbara S Craft, Razelle Kurzrock, Xiudong Lei, et al.
Eclinicalmedicine|June 24, 2022
Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumoursDaniel D Karp, D Ross Camidge, Jeffery R Infante, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Phase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancerWilliam N William, Ralph G Zinner, Daniel D Karp, et al.
Journal of Clinical and Translational Science|February 22, 2024
Simultaneous submission of seven CTSA proposals: UM1, K12, R25, T32-predoctoral, T32-postdoctoral, and RC2: strategies, evaluation, and lessons learnedCarolina Lema, Kwai Wa Cheng, Delanderia M Anderson, et al.
Pageof 11